Intention to adhere to HIV treatment: A patient-centred predictor of antiretroviral adherence

HIV Medicine

Volumn 14, Issue 8, 2013, Pages 472-480

  Nelsen, A ^a,b   Gupta, S ^a,b,c   Trautner, Bw ^a,b,c   Petersen, Nj ^a,b   Garza, A ^a   Giordano, Tp ^a,b,c   Naik, Ad ^a,b   Rodriguez Barradas, Maria C ^a,b,c  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HARRIS COUNTY HOSPITAL DISTRICT   (United States)

Author keywords

Adherence; Highly active antiretroviral therapy; HIV; Intention; Predictors

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; AWARENESS; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEALTH LITERACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICATION COMPLIANCE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT DECISION MAKING; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES; VIRUS LOAD;

ADHERENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV; INTENTION; PREDICTORS;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DATA COLLECTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INTENTION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; SELF REPORT; TEXAS;

EID: 84881315620     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12032     Document Type: Article

References (53)

1. Horstmann E, Brown J, Islam F, Buck J, Agins B. Retaining HIV-infected patients in care: where are we? Where do we go from here? Clin Infect Dis 2010; 50: 52-61.
2. 10 Leading Causes of Death by Age Group-United States. 2008. Centers for Disease Control and Prevention. 9-3-2010. 12-2-2011. Ref Type: Online Source.
3. Wainberg M, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998; 279: 977-983.
4. Marks G, Gardner L, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS 2010; 24: 665-678.
5. Stone V. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis 2001; 33: 65-72.
6. Paterson D, Swindells S, Mohr J etal. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133: 1-30.
7. Ickovics J, Meade C. Adherence to HAART among patients with HIV: breakthroughs and barriers. AIDS Care 2002; 14: 09-18.
8. Panel on Antiretrovial Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. D-1. 2012. Department of Health and Human Services. 6-28-2012. Ref Type: Online Source.
9. Mills E, Nachega J, Buchan I etal. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006; 296: 79-90.
10. Boarts J, Sledjeski E, Bogart L, Delahanty D. The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS Behav 2006; 10: 53-61.
11. Kalichman S, Pope H, White D etal. The association between health literacy and HIV treatment adherence: further evidence from objectively measured medication adherence. J Int Assoc Physicians AIDS Care 2008; 7: 17-23.
12. Mohammed H, Kieltyka L, Richardson-Alston G etal. Adherence to HAART among HIV-infected persons in rural Louisiana. AIDS Patient Care STDS 2004; 18: 89-96.
13. Ickovics J, Meisler A. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol 1997; 50: 85-91.
14. Schneider J, Kaplan S, Greenfield S, Li W, Wilson I. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med 2004; 19: 096-103.
15. Stone V, Jordan J, Tolson J, Miller R, Pilon T. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral thearpy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence. J Acquir Immune Defic Syndr 2004; 36: 08-16.
16. Beach M, Duggan P, Moore R. Is patients' preferred involvement in health decisions related to outcomes for patients with HIV? J Gen Intern Med 2006; 22: 119-124.
17. Osborn C, Davis T, Bailey S, Wolf M. Health literacy in the context of HIV treatment: introducing the brief estimate of health knowledge and action (BEHKA)-HIV version. AIDS Behav 2010; 14: 81-88.
18. Fumaz C, Munoz-Moreno J, Molto J etal. Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs. AIDS Care 2008; 20: 96-805.
19. Kalichman S, Cain D, Fuhrel A, Eaton L, Di Fonzo K, Ertl T. Assessing medication adherence self-efficacy among low-literacy patients: development of a pictographic visual analogue scale. Health Educ Res 2005; 20: 4-35.
20. Murphy D, Marelich W, Rappaport N, Hoffman D, Farthing C. Results of an antiretroviral adherence intervention: STAR (staying healthy: taking antiretrovirals regularly). J Int Assoc Physicians AIDS Care 2007; 6: 13-24.
21. Simoni J, Amico K, Smith L, Nelson K. Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep 2010; 7: 4-51.
22. Weiss L, French T, Finkelstein R, Waters M, Mukherjee R, Agins B. HIV-related knowledge and adherence to HAART. AIDS Care 2003; 15: 673-679.
23. Nelsen A, Trautner B, Petersen N etal. Development and validation of a measure for intention to adhere to HIV. AIDS Pt Care STDs 2012; 26: 29-34.
24. Naik A, Dyer C, Kunik M, McCullough L. Patient autonomy for the management of chronic conditions: a two-component re-conceptualization. Am J Bioeth 2009; 9: 3-30.
25. Deber R, Kraetschmer N, Irvine J. What role do patients wish to play in treatment decision making? Arch Intern Med 1996; 156: 414-420.
26. Chew L, Griffin J, Parin M etal. Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med 2008; 23: 61-66.
27. Wallace L, Rogers E, Roskos S, Holiday D, Weiss B. Brief report: screening items to identify patients with limited health literacy skills. J Gen Intern Med 2006; 21: 74-77.
28. Naik A, Kallen M, Walder A etal. Improving hypertension control in diabetes mellitus: the effects of collaborative and proactive health communication. Circulation 2008; 117: 361-368.
29. Schwarzer R, Sneihotta F, Lippke S etal. On the Assessment and Analysis of Variables in the Health Action Process Approach: Conducting An Investigation. Berlin, Freie Universeitat Berlin, 2003.
30. Giordano T, Guzman D, Clark R, Charlebois E, Bangsberg D. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials 2004; 5: 4-9.
31. Chesney M, Ickovics J, Chambers A etal. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care 2000; 12: 55-66.
32. Buscher A, Hartman C, Kallen M, Giordano T. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naive, HIV patients. HIV Clin Trials 2011; 12: 44-54.
33. Bangsberg D. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral supression. Clin Infect Dis 2006; 43: 39-41.
34. Maggiolo F, Ravasio L, Ripamonti D etal. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis 2005; 40: 58-63.
35. Kobin A, Sheth N. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother 2011; 45: 72-79.
36. Cooper V, Horne R, Gellaitry G etal. The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study. J Acquir Immune Defic Syndr 2010; 53: 69-77.
37. Murray L, Semrau K, McCurley E etal. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care 2009; 21: 78-86.
38. Ramirez Garcia P, Côté J. Factors affecting adherence to antiretroviral therapy in people living with HIV/AIDS. J Assoc Nurses AIDS Care 2003; 14: 7-45.
39. Fishbein M. The role of theory in HIV prevention. AIDS Care 2000; 12: 73-78.
40. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991; 50: 179-211.
41. Fishbein M. A reasoned action approach to health promotion. Med Decis Making 2008; 28: 34-44.
42. Armitage C, Conner M. Distinguishing perceptions of control from self-efficacy: predicting consumption of a low-fat diet using the theory of planned behavior. J Appl Soc Psychol 1999; 29: 72-90.
43. Boudreau F, Godin G. Understanding physical activity intentions among French Candadians with type 2 diabetes: an extension of Ajzen's theory of planned behaviour. Int J Behav Nutr Phys Act 2009; 6: 35.
44. Godin G, Valois P, Lepage L, Desharnais R. Predictors of smoking behaviour: an application of Ajzen's theory of planned behaviour. Br J Addict 1992; 87: 335-343.
45. Van Ryn M, Lutle L, Kirscht J. A test of the theory of planned behavior for two health-related practices. J Appl Soc Psychol 1996; 26: 871-883.
46. Montano D, Taplin S. A test of an expanded theory of reasoned action to predict mammography participation. Soc Sci Med 1991; 32: 33-41.
47. Brubaker R, Fowler C. Encouraging college males to perform testicular self-examination: evaluation of a persuasive message based on the revised theory of reasoned action. J Appl Soc Psychol 1990; 17: 1411-1422.
48. Gummeson L, Jonsson I, Conner M. Predicting intentions and behavior of Swedish 10-16-year-olds at breakfast. Food Qual Prefer 1997; 8: 297-306.
49. Hillhouse J, Adler C, Drinnon J, Turrisi R. Application of Ajzen's theory of planned behavior to predict sunbathing, tanning salon use, and sunscreen use intentions and behaviors. J Behav Med 1997; 20: 365-378.
50. Renner B, Kwon S, Yang B. Social-cognitive predictors of dietary behaviors in South Korean men and women. Int J Behav Med 2008; 15: 313.
51. Gross R, Bilker W, Friedman H, Strom B. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 2001; 15: 109-117.
52. Naik A, Isaac T, Street R, Kunik M. Understanding the quality chasm for hypertension control in diabetes: a structured review of "co-maneurvers" used in clinical trials. J Am Board Fam Med 2007; 20: 69-78.
53. Oettingen G, Mayer D. The motivating function of thinking about the future: expectations versus fantasies. J Pers Soc Psychol 2002; 83: 198-212.